End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.4 CNY | -0.40% | -0.54% | +5.56% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
Sales 2024 * | 170B 23.52B | Sales 2025 * | 191B 26.37B | Capitalization | 28.18B 3.89B |
---|---|---|---|---|---|
Net income 2024 * | 2.69B 371M | Net income 2025 * | 3.18B 439M | EV / Sales 2024 * | 0.22 x |
Net Debt 2024 * | 9.24B 1.28B | Net Debt 2025 * | 12.56B 1.73B | EV / Sales 2025 * | 0.21 x |
P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
9.5
x | Employees | 30,100 |
Yield 2024 * |
4.46% | Yield 2025 * |
4.72% | Free-Float | 40.28% |
1 day | -0.40% | ||
1 week | -2.12% | ||
Current month | -9.87% | ||
1 month | -9.87% | ||
3 months | -7.50% | ||
6 months | -1.46% | ||
Current year | +5.56% |
Managers | Title | Age | Since |
---|---|---|---|
Wei He
CEO | Chief Executive Officer | 38 | 21-09-30 |
Chang Yun Liu
CHM | Chairman | 42 | 17-07-31 |
Ying Zheng Xu
CHM | Chairman | 51 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gu Liang Tang
BRD | Director/Board Member | 62 | 20-11-04 |
Bao Lin Liu
FOU | Founder | 71 | 99-02-28 |
Zhao Nian Liu
BRD | Director/Board Member | 64 | 08-11-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 2 M€ | -18.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7.4 | -0.40% | 12,337,290 |
24-05-30 | 7.43 | +0.27% | 8,547,156 |
24-05-29 | 7.41 | -.--% | 15,307,430 |
24-05-28 | 7.41 | -4.63% | 24,057,040 |
24-05-27 | 7.77 | +4.44% | 25,476,210 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.56% | 3.91B | |
+23.03% | 72.92B | |
-1.52% | 23.8B | |
+3.67% | 8.38B | |
+8.55% | 8.33B | |
-23.71% | 7.66B | |
+15.20% | 5.13B | |
-6.90% | 4.18B | |
+2.68% | 4.06B | |
+18.80% | 3.58B |
- Stock Market
- Equities
- 600998 Stock